The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2

References

• Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30(12):1856–1883.
   PubMed Web of Science ®Google Scholar
• Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16(1):17–29.
   PubMed Web of Science ®Google Scholar
• Lamartina L, Grani G, Durante C, et al. Screening for differentiated thyroid cancer in selected populations. Lancet Diabetes Endocrinol. 2020;8(1):81–88.
   PubMed Web of Science ®Google Scholar
• Krishnan A, Berthelet J, Renaud E, et al. Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas. Nat Commun. 2020;11(1):2056.
   PubMed Web of Science ®Google Scholar
• Rubinstein JC, Nicolson NG, Rottmann D, et al. Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients. Ann Oncol. 2020;31(6):815–821.
   PubMed Web of Science ®Google Scholar
• Yu J, Deng Y, Liu T, et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat Commun. 2020;11(1):4807.
   PubMed Web of Science ®Google Scholar
• Sollini M, Chiti A. Concerns about the risk of myeloid malignancies after radioiodine therapy in thyroid cancer. J Clin Oncol. 2018;36(18):1885–1886.
   PubMed Web of Science ®Google Scholar
• Huang Y, Qu S, Zhu G, et al. BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment. J Natl Cancer Inst. 2018;110(4):362–370.
   PubMedGoogle Scholar
• Aguilar C, Mano M, Eulalio A. MicroRNAs at the host-bacteria interface: host defense or bacterial offense. Trends Microbiol. 2019;27(3):206–218.
   PubMed Web of Science ®Google Scholar
• Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, et al. microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Res Rev. 2019;49:125–143.
   PubMed Web of Science ®Google Scholar
• Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147.
   PubMed Web of Science ®Google Scholar
• Hirahata M, Osaki M, Kanda Y, et al. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma. Cancer Med. 2016;5(5):892–902.
   PubMed Web of Science ®Google Scholar
• Li WH, Wu HJ, Li YX, et al. MicroRNA-143 promotes apoptosis of osteosarcoma cells by caspase-3 activation via targeting Bcl-2. Biomed Pharmacother. 2016;80:8–15.
   PubMed Web of Science ®Google Scholar
• Wang L, He J, Xu H, et al. MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer. Am J Transl Res. 2016;8(6):2716–2726.
   PubMed Web of Science ®Google Scholar
• Chang YY, Kuo WH, Hung JH, et al. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing. Mol Cancer. 2015;14(1):36.
   PubMedGoogle Scholar
• Zhang Y, Wang Z, Chen M, et al. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer. 2012;11(1):23.
   PubMed Web of Science ®Google Scholar
• Yu Y, Gao F, He Q, et al. lncRNA UCA1 Functions as a ceRNA to promote prostate cancer progression via sponging miR143. Mol Ther Nucleic Acids. 2020;19:751–758.
   PubMedGoogle Scholar
• Wang ZL, Wang C, Liu W, et al. Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2. Exp Mol Pathol. 2020;112:104342.
   PubMed Web of Science ®Google Scholar
• Chiappetta G, Ferraro A, Vuttariello E, et al. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. Eur J Cancer. 2008;44(7):1015–1021.
   PubMed Web of Science ®Google Scholar
• Samija I, Matesa N, Kozaj S, et al. HMGA2 gene expression in fine-needle aspiration samples of thyroid nodules as a marker for preoperative diagnosis of thyroid cancer. Appl Immunohistochem Mol Morphol. 2019;27(6):471–476.
   PubMedGoogle Scholar
• Wu ZY, Wang SM, Chen ZH, et al. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer. Cancer Biomark. 2015;15(5):535–542.
   PubMed Web of Science ®Google Scholar
• Damanakis AI, Eckhardt S, Wunderlich A, et al. MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5. J Cancer Res Clin Oncol. 2016;142(6):1213–1220.
   PubMed Web of Science ®Google Scholar
• Si Z, Yu L, Jing H, et al. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis. J Exp Clin Cancer Res. 2021;40(1):78.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Greenspan BS. Radio-iodine treatment of well differentiated thyroid cancer: balancing risks and benefits. J Clin Oncol. 2018;36(18):1785–1787.
   PubMed Web of Science ®Google Scholar
• Si Z, Wang X. The neuroprotective and neurodegeneration effects of heme oxygenase-1 in alzheimer’s disease. J Alzheimers Dis. 2020;78(4):1259–1272.
   PubMed Web of Science ®Google Scholar
• Capdevila J, Mayor R, Mancuso FM, et al. Early evolutionary divergence between papillary and anaplastic thyroid cancers. Ann Oncol. 2018;29(6):1454–1460.
   PubMed Web of Science ®Google Scholar
• Noguchi S, Mori T, Hoshino Y, et al. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett. 2011;307(2):211–220.
   PubMed Web of Science ®Google Scholar
• Takai T, Tsujino T, Yoshikawa Y, et al. Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS networks of renal cell cancer cells in vitro and in vivo. Mol Ther. 2019;27(5):1017–1027.
   PubMed Web of Science ®Google Scholar
• Zhao S, Liu H, Liu Y, et al. miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. Cancer Lett. 2013;333(2):253–260.
   PubMed Web of Science ®Google Scholar
• Gao Y, Tang Y, Sun Q, et al. Circular RNA FOXP1 relieves trophoblastic cell dysfunction in recurrent pregnancy loss via the miR-143-3p/S100A11 cascade. Bioengineered. 2021;12(1):9081–9093.
   PubMed Web of Science ®Google Scholar
• Liu XX, Bao QX, Li YM, et al. The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p/VDAC1 pathway. Bioengineered. 2021;12(1):3322–3335.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020;11(1):11–18.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu S, Hu T, et al. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 2009;50(2):490–499.
   PubMed Web of Science ®Google Scholar
• Zhang S, Mo Q, Wang X. Oncological role of HMGA2 (Review). Int J Oncol. 2019;55(4):775–788.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Ditzel HJ, et al. HMGA2 as a Critical Regulator in Cancer Development. Genes (Basel). 2021;13(1):12.
   PubMedGoogle Scholar
• Fedele M, Visone R, De Martino I, et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell. 2006;9(6):459–471.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Duijf PHG, and Mohammadi A, et al. Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness. Expert Opin Ther Targets. 2020 Mar 14;1–11.
   PubMed Web of Science ®Google Scholar
• Natarajan S, Hombach-Klonisch S, Droge P, et al. HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells. Neoplasia. 2013;15(3):263–280.
   PubMed Web of Science ®Google Scholar
• Xi X, Teng M, Zhang L, et al. Retracted: microRNA-204-3p represses colon cancer cells proliferation, migration, and invasion by targeting HMGA2. J Cell Physiol. 2020;235(2):1330–1338.
   PubMed Web of Science ®Google Scholar
• Ma J, Li D, Kong FF, et al. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development. J Exp Clin Cancer Res. 2018;37(1):19.
   PubMedGoogle Scholar